At Basilobio, we are a biotechnology-driven company committed to innovation in probiotics, ginseng extracts, and memory-enhancing solutions. Established in 2024, our foundation is built on extensive government-backed research in lactic acid bacteria cultivation. Our flagship product, Basilopet, is the world’s first probiotic designed to survive throughout an animal’s lifetime, setting a new standard in pet health. Our expertise extends to Bacillus coagulans, a highly effective Korean probiotic strain, and ginsenoside extraction technology, enabling the conversion of water-soluble ginseng compounds into fat-soluble forms for enhanced absorption. Scientific research, innovation, and product efficacy drive our commitment to developing high-quality raw materials and health-enhancing solutions. With a vision to redefine the future of nutraceuticals, we continuously explore cutting-edge biotechnologies to deliver proven and effective solutions to the global market.